• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION REVACLEAR 300; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION REVACLEAR 300; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 114745
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Hemolysis (1886); Chest Tightness/Pressure (2463)
Event Date 10/05/2020
Event Type  Injury  
Manufacturer Narrative
Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that during home dialysis treatment with a revaclear 300 dialyzer, the patient experienced severe abdominal pain, chest pressure and yellowing of the eyes.The treatment was set to eight (08) hours with a total ultrafiltration (uf) volume of 4500 ml.It was reported that after 4h 40 minutes of treatment, the patient experienced severe abdominal pain.Treatment was discontinued with blood return.The patient allegedly observed the presence of clear blood in the anticoagulant line, but no leakage was reported.The following day, the patient experienced pressure in the chest and their eyes were observed to be "yellowish".The patient went to the emergency room and was treated with 50 mg tramal (tramadol) for stomach ache and the patient returned home the same evening.The patient was diagnosed with hemolysis.No additional information is available.
 
Manufacturer Narrative
H10: the actual device was received for evaluation.The visual inspection and measurements of the inner diameters were within product specification.The reported condition was not verified.The cause of the reported problem could not be determined.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REVACLEAR 300
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
MDR Report Key10765499
MDR Text Key214150748
Report Number9611369-2020-00148
Device Sequence Number1
Product Code KDI
Combination Product (y/n)Y
PMA/PMN Number
K130039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 12/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number114745
Device Lot NumberASKU
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/05/2020
Initial Date Manufacturer Received 10/06/2020
Initial Date FDA Received10/30/2020
Supplement Dates Manufacturer Received11/12/2020
Supplement Dates FDA Received12/02/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AK 98 V2 230V, SELF-CARE.; NOVALINE BL207.; WRO300H.
Patient Outcome(s) Required Intervention;
Patient Age30 YR
-
-